Clinical Trials Directory

Trials / Terminated

TerminatedNCT00919126

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

An International Phase III Randomised Trial Comparing the Propofol Consumption During General Anaesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia Alone in ASA III Patients With Increased Risk of Perioperative Cardiac Complications.

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Air Liquide SA · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the quantity of propofol administered with Xenon in two inspiratory concentrations, to maintain comparable depth of anaesthesia during the maintenance period of general anaesthesia.

Detailed description

The inert or "noble" gas Xenon has anaesthetic properties that have been recognized 50 years ago. Several preclinical studies and investigations using xenon as an inhalational anaesthetic in humans were performed and reported that this gas has many properties of the ideal anaesthetic agent. Moreover, it is known that when xenon is combined with volatile anaesthetics or opioids, the required doses of those substances are reduced, resulting in a lower incidence of side effects. Patients could benefit from the administration of xenon if this inspired concentration would result in reduced doses of co-administered drugs. This trial should allow evaluating the propofol consumption required in combination with xenon administered in inspiratory concentrations of 50% and 70% to maintain comparable depth of general anaesthesia as total i.v. anaesthesia, in ASA III patients presenting increased risk of perioperative cardiac complications and undergoing laparotomy or orthopaedic surgery.

Conditions

Interventions

TypeNameDescription
DRUGXenonMaintenance of anaesthesia obtained with Xenon 50% and propofol infusion adjusted to depth of anaesthesia.
DRUGXenonMaintenance of anaesthesia obtained with Xenon 70% and propofol infusion adjusted to depth of anaesthesia.
DRUGMedical Air in OxygenMaintenance of anaesthesia obtained with propofol infusion adjusted to depth of anaesthesia.

Timeline

Start date
2009-06-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2009-06-12
Last updated
2014-09-25
Results posted
2014-07-17

Locations

6 sites across 3 countries: France, Germany, United Kingdom

Source: ClinicalTrials.gov record NCT00919126. Inclusion in this directory is not an endorsement.